IQVIA Announces Connected Intelligence™
28 April 2021 - 10:00PM
Business Wire
IQVIA (NYSE: IQV), a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry, today announced Connected
Intelligence™, its innovative approach to enabling life sciences
customers to discover powerful new insights, drive smarter
decision-making, and get treatments to patients faster.
Connected Intelligence brings together IQVIA’s unique portfolio
of capabilities to create intelligent connections across its
unparalleled healthcare data, advanced analytics, innovative
technologies, and healthcare expertise to speed the development and
commercialization of innovative medicines that improve patient
lives. Connected Intelligence provides new levels of value across
clinical, compliance and commercial stakeholders within pharma, med
tech, payers, providers, and government organizations.
IQVIA’s Connected Intelligence in action includes:
- Connecting data, analytics, and services to accelerate more
than 350 ongoing clinical research studies to find treatments and
novel vaccines for COVID-19
- Deploying innovative technologies across 60 ongoing
decentralized clinical trials spanning 40 countries utilizing
IQIVA’s virtual capabilities to enroll more than 170,000 patients
globally
- Bringing together big data, advanced analytics, and healthcare
expertise to help industry professionals better understand
diseases, their spread and outcomes
- Accelerating drug discovery by creating intelligent connections
across private companies, government agencies, and university
researchers
- Linking real world data and healthcare expertise to enable
contact tracing and COVID-19 testing protocols to reveal novel
disease insights
The world is counting on the healthcare industry for innovations
and scientific breakthroughs to improve societal health. IQVIA,
recognizing that the healthcare industry needs to increase agility
and accelerate results, has made significant investments and
commitment to the healthcare ecosystem, and has the global scale
and experience to deliver a completely new approach to moving
healthcare forward.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions, and clinical research services to
the life sciences industry. IQVIA creates intelligent connections
across all aspects of healthcare through its analytics,
transformative technology, big data resources and extensive domain
expertise. IQVIA Connected Intelligence™ delivers powerful insights
with speed and agility — enabling customers to accelerate the
clinical development and commercialization of innovative medical
treatments that improve healthcare outcomes for patients. With
approximately 72,000 employees, IQVIA conducts operations in more
than 100 countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210428005564/en/
Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com) +1.484.567.6732
Nick Childs, IQVIA Investor Relations (Nchilds@us.imshealth.com)
+1.973.316.3828
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2024 to May 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From May 2023 to May 2024